Insulin Degludec API from Japan
Ultra-long acting insulin analogue with side chain modification for multi-hexamer formation. rDNA product classified in 2937.12.00.00 as polypeptide hormone structural analogue.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide peer-reviewed structural characterization of degludec modifications
• Special cold chain for ultra-long acting formulations; stability data required
• Bulk API form maintains Chapter 29 classification; avoid dosage declarations